Dr. Jonathan (Josh) Bloom, ACSH's Director of Chemical and Pharmaceutical Sciences, earned his Ph.D. in organic chemistry at the University of Virginia and completed postdoctoral training at the University of Pennsylvania. He spent more than 20 years in drug discovery at Wyeth, working on treatments for diabetes, obesity, infectious diseases, and other conditions. His research group discovered the antibiotic Tygacil®, approved in 2005 to treat resistant bacterial infections.

Dr. Bloom holds 25 issued patents and has authored 35 academic papers, including a chapter on hepatitis C in Burger’s Medicinal Chemistry, Drug Discovery, and Development. Since joining ACSH in 2010, he has written more than 2,000 articles and dozens of op-eds for publications including The Wall Street Journal, New York Post, Chicago Tribune, Philadelphia Inquirer, and New York Daily News.

My books: